... frompatients with DLTs. The significance of increases in Th17disappeared from the group of patients with non-DLT tox-icities. Of note, patients with the highest levels of Th17cells were not the ones ... a proportion (pre-dosingmean of 73,711 with 95% confidence interval of 46,912–100,510, compared with post-dosing mean of 101,066 with 95% confidence interval of 70,644–131,488, p =0.026). ... the levels of Th17 cells between patients with or without an objective tumorresponse, but samples from patients with inflammatory and autoimmune toxicities during the firstcycle of therapy...